Bliss GVS Pharma hit an upper circuit limit of 10% at Rs 173.10 at 15:15 IST on BSE on bargain hunting after the stock fell 10.52% in the preceding four trading sessions to Rs 157.40 on 13 July 2015 from a recent high of Rs 175.90 on 7 July 2015.
Meanwhile, the BSE Sensex was down 3.97 points, or 0.01%, to 27,957.22.
On BSE, so far 5.72 lakh shares were traded in the counter, compared with an average volume of 95,383 shares in the past one quarter.
The stock hit a high of Rs 173.10 and a low of Rs 157.50 so far during the day. The stock hit a record week high of Rs 187.90 on 6 July 2015. The stock hit a 52-week low of Rs 45.05 on 8 August 2014.
The stock had outperformed the market over the past one month till 13 July 2015, rising 42.57% compared with 5.81% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 11.24% as against Sensex's 3.73% fall.
The small-cap company has an equity capital of Rs 10.31 crore. Face value per share is Re 1.
More From This Section
Bliss GVS Pharma's net profit surged 327.8% to Rs 6.46 crore on 26.5% rise in net sales to Rs 67.96 crore in Q4 March 2015 over Q4 March 2014.
Bliss GVS is a fast-growing pharmaceutical company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.
Powered by Capital Market - Live News